URGN earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -15.29. Updated 2026-07-23.
UroGen Pharma (URGN) Research Hub
UroGen Pharma (URGN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 42.31 USD (-5.98%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -15.29, market cap 2.09B. This hub links to the full technical, earnings and options research available for URGN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 42.31 USD (-5.98%) |
| 52-week range | 29.46 USD – 50.81 USD |
| Trend regime | Range |
| 14-day RSI | 36 (Bearish) |
| Trailing P/E | -15.29 |
| Market cap | 2.09B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for URGN
Covered Call on URGN: how it works, illustrative setup around the real 42.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on URGN: how it works, illustrative setup around the real 42.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on URGN: how it works, illustrative setup around the real 42.31 USD price, max profit/loss, breakeven and when to use it. Educational.
URGN technical analysis: range, last 42.31 USD, RSI 36, 52w range 29.46 USD–50.81 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is URGN in?
UroGen Pharma (URGN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is URGN in an uptrend or downtrend?
As of 2026-09-11, URGN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is URGN's trailing P/E ratio?
URGN's trailing P/E is -15.29, with a market cap of 2.09B. See the earnings research page for full valuation detail.
When does URGN next report earnings?
URGN is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.28 USD.